Amgen mourns death of George Rathmann, founding CEO
Biotech giant Amgen‘s (NSDQ:AMGN) founding CEO George Rathmann died this week at the age of 84. In his final years, Rathmann was a dialysis patient who took EPO, a red blood cell stimulating hormone he helped pioneer in Amgen’s early days. Read more
SeraCare names Charlie Mamrak CEO following close of merger with Linden Capital Partners
Pro-Dex names board member Michael Berthelot CEO following resignation of Mark Murphy
Rockwell Medical Tech. hires Dr. Raymond Pratt as chief medical officer
ReVision Optics appoints Dr. Stephen Slade to board
SafeStitch Medical launches nationwide sales team
NovaSom names Dr. Michael Coppola chief medical officer, VP of medical affairs
LDR Holding announces Robert McNamara chief financial officer
Nephros appoints former CorMedix Inc. chief John Houghton president & CEO
Orgenesis names former FDA medical officer Dr. G. Alexander Fleming to board
Digirad Corp. board loses Steven Mendell, adds Jeffrey Eberwein, Charles Gillman, James Hawkins
OmniGuide makes former Smith & Nephew joint repair leader Carl Vause VP of marketing
Angeion Corp. adds former Sarnova chief Hendrik Struik to board
Sanuwave director Ronald Sparks, Jr., resigns from board “for personal reasons”
Encision Inc. names Pico LLC owner Dr. Patrick Pace to board
Medical Action Industries appoints John Sheffield CFO
Organovo promotes Sharon Collins Presnell to chief technical officer, as well as VP of R&D, and appoints Michael Renard executive VP of commercial operations
Cantel Medical announces Seth Yellin VP of corporate development